MedTrace Logo

Virtual Reality Digital Therapeutics for Seasonal Affective Disorder

NCT07161570 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-09-08

No results posted yet for this study

Summary

Seasonal Affective Disorder (SAD) is commonly treated with bright light therapy. Virtual reality (VR) is an immersive computer-generated environment, which has been used to treat mental health difficulties, such as depression, social anxiety and stress. This study aims to compare the use of VR with bright light therapy in treating SAD.

Participants will be randomly allocated to either the VR condition or the light box condition and instructed to use the respective device every day for 14 days.

Conditions

  • Seasonal Affective Disorder (SAD)

Interventions

DEVICE

Virtual Reality (VR) Intervention

10-min VR intervention, once a day, everyday for 14 days.

DEVICE

Light Box (LB) intervention

30-min LB intervention once a day, everyday for 14 days.

Sponsors & Collaborators

  • Reneural Technologies Ltd.

    collaborator UNKNOWN

  • Aerial Icon Ltd.

    collaborator UNKNOWN

  • Innovate UK, UKRI

    collaborator UNKNOWN

  • Anglia Ruskin University

    lead OTHER

Principal Investigators

  • Debora Vasconcelos e Sa, PhD · Anglia Ruskin University

  • Jane Scott, PhD · Anglia Ruskin University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-27
Primary Completion
2026-03-31
Completion
2026-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07161570 on ClinicalTrials.gov